8-K: Premier Inc. Reports Fiscal Year 2025 First Quarter Results, Reaffirms Full-Year Guidance

Premier, Inc. announced its fiscal year 2025 first-quarter results, slightly exceeding expectations for revenue and profitability and reaffirming its full-year guidance.

Summary

• Premier, Inc. reported a decrease in net revenue of 8% to $248.1 million for the first quarter of fiscal year 2025 compared to the same period last year.
• Net income from continuing operations increased significantly by 75% to $72.9 million, primarily due to a $57 million non-operating gain from a derivative lawsuit settlement.
• Adjusted EBITDA decreased by 33% to $62.4 million, and adjusted earnings per share (EPS) decreased by 28% to $0.34.
• The company's Supply Chain Services segment saw a 7% decrease in net revenue, while Performance Services experienced a 9% decrease.
• Premier reaffirmed its fiscal year 2025 guidance, projecting total net revenue excluding Contigo Health between $930 million and $1.02 billion, adjusted EBITDA between $235 million and $255 million, and adjusted EPS between $1.16 and $1.28.
• The company repurchased 2.9 million shares for $58 million in market transactions in addition to the 19.9 million shares repurchased under the accelerated share repurchase program.
• A quarterly cash dividend of $0.21 per share was declared, payable on December 15, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While the company exceeded expectations for revenue and profitability, the significant decreases in adjusted EBITDA, adjusted net income, and adjusted EPS, along with the revenue decline, temper the positive aspects. The reaffirmation of guidance provides some reassurance, but the overall financial performance is concerning.

Positives

• The company's first-quarter results slightly exceeded expectations for total net revenue and profitability.
• Premier reaffirmed its full-year fiscal 2025 guidance.
• Net income from continuing operations increased significantly due to a non-operating gain.
• The company continued to return capital to stockholders through dividends and share repurchases.
• Free cash flow increased compared to the prior year period.
• Software license and other services revenue in the Supply Chain Services segment increased by 40%.

Negatives

• Total net revenue decreased by 8% compared to the prior year period.
• Adjusted EBITDA decreased by 33% compared to the prior year period.
• Adjusted net income decreased by 38% compared to the prior year period.
• Adjusted EPS decreased by 28% compared to the prior year period.
• Both Supply Chain Services and Performance Services segments experienced revenue declines.
• Net administrative fees revenue decreased by 12% due to an increase in the aggregate blended member fee share.

Risks

• The company's revenue is subject to fluctuations due to the timing of engagements and contract renewals.
• The ongoing divestiture process for the Contigo Health business may impact future financial results.
• The company faces challenges in the consulting business due to lower demand.
• The company is exposed to risks related to supply chain disruptions, such as the recent IV solution shortage.
• The company's performance is subject to the impact of changes in healthcare regulations and policies.
• The company's free cash flow is typically lowest in the first quarter due to the timing of certain expenses.

Future Outlook

Premier reaffirmed its fiscal 2025 guidance, projecting total net revenue excluding Contigo Health between $930 million and $1.02 billion, adjusted EBITDA between $235 million and $255 million, and adjusted EPS between $1.16 and $1.28. The company expects a sequential decline in net administrative fees revenue in the second quarter due to ongoing contract renewals and anticipates that revenue in the Performance Services business will be more back-half weighted.

Management Comments

• Michael J. Alkire, Premier's President and CEO, stated that the first quarter results slightly exceeded expectations for total net revenue and profitability.
• Alkire emphasized the company's focus on technology-driven solutions to address core challenges faced by members and customers.
• Craig McKasson, Chief Administrative and Financial Officer, noted that the GPO renewal process is going according to plan and that the company had a stronger underlying performance in purchasing from health systems in the first quarter.
• McKasson also mentioned that the company expects to have fee share be in the low 60s throughout fiscal 2025.
• McKasson highlighted that the company is focused on a balanced approach to capital deployment, including returning capital to stockholders and investing in organic growth and potential acquisitions.
• Alkire mentioned that the company is working with health systems, the federal government, and other suppliers to mitigate the impact of the IV solution shortage.

Industry Context

This announcement comes as healthcare providers face increasing pressure to reduce costs and improve outcomes. Premier's focus on technology-driven solutions and its group purchasing organization (GPO) model positions it to address these challenges. The company's efforts to mitigate supply chain disruptions, such as the IV solution shortage, are also relevant in the current healthcare environment. The divestiture of the S2S Global direct sourcing business and the ongoing divestiture process for the Contigo Health business reflect a strategic shift towards core operations and technology-enabled services.

Comparison to Industry Standards

• Premier's revenue decline of 8% is notable in the context of the broader healthcare industry, where many companies are experiencing growth or stable performance.
• The 33% decrease in adjusted EBITDA is significant and may raise concerns among investors, especially when compared to peers with more stable profitability.
• The company's focus on technology and data analytics aligns with industry trends, but its ability to execute on these strategies will be critical for future success.
• The share repurchase program and dividend payments are consistent with industry practices for returning capital to shareholders, but the company's overall financial performance will need to improve to support these initiatives.
• Compared to companies like Medline and Cardinal Health, which also operate in the healthcare supply chain, Premier's results show a more significant impact from contract renewals and fee share adjustments.
• The company's performance in the Performance Services segment is weaker than some competitors in the healthcare consulting space, such as Accenture and Deloitte, which have seen more robust growth in recent periods.

Management Changes

Stakeholder Impact

• Shareholders will be impacted by the share repurchase program and dividend payments.
• Employees may be affected by the company's restructuring and cost-cutting measures.
• Customers, including hospitals and health systems, will be impacted by the company's supply chain and performance improvement services.
• Suppliers will be impacted by the company's purchasing decisions and contract negotiations.
• Creditors will be impacted by the company's financial performance and debt management.

Next Steps

• The company will continue to execute its share repurchase program.
• Premier will continue to evaluate opportunities to invest in organic growth and potential acquisitions.
• The company will continue to work through the ongoing GPO contract renewal process.
• Premier will continue to monitor the impact of the IV solution shortage and other supply chain disruptions.
• The company will file its Form 10-Q for the quarter ended September 30, 2024, with the SEC.

Key Dates

Keywords

healthcare, supply chain, group purchasing, performance services, technology, EBITDA, revenue, share repurchase, dividends, financial results